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Background:  Parthenin is a natural product with a wide array of biological effects that is 
derived from the invasive and damaging weed, Parthenium hysterophorus. Parthenin is 
closely related in structure to artemisinin, which is one of the most important antimalarial 
drugs in the world today. Both compounds are sesquiterpene lactones and research 
shows that parthenin also has an effect on Plasmodium blood stage development. This 
study did not evaluate parthenin as a potential therapeutic against blood stages but rather 
examined the effect of the compound on the transmissible stages of the parasite within the 
mosquito to gain potential mechanistic insight. This research could help identify a possible 
mode of action of parthenin, which may be different from artemisinin; and therefore pave 
the way for the development compounds more suitable as drugs that would be effective 
against artemisinin-resistant parasites. 
Methods:  We analyzed the developmental stages of Plasmodium in reverse order in the 
mosquito. First, serial dilutions of parthenin were included in Plasmodium falciparum 
gametocytemic blood and fed to Anopheles gambiae mosquitoes to evaluate the effect of 
the compound on oocyst infection intensity. Ookinete development in the presence of 
parthenin was subsequently evaluated by immunofluorescence as well as by imaging flow 
cytometry using a cultureable strain of Plasmodium berghei. Male microgamete 
exflagellation following 16 min incubation with parthenin was quantified by manual 
counting under phase contrast microscopy. Finally, to determine if parthenin can act on 
quiescent stage V gametocytes, the parasites were exposed to parthenin for 24 hours, 
and fed to mosquitoes without the compound present in the blood meal. 




falciparum oocyst numbers and was statistically significant at 100, 50 and 25 µg/mL. 
Ookinete formation in the midgut was also inhibited in a similar fashion at similar 
concentrations and imaging flow cytometry also demonstrated the absence of mature, in 
vitro cultured P. berghei ookinetes. As suspected, microgametocyte exflagellation was 
significantly inhibited by the compound, which directly impacts the number of ookinete 
produced. P. falciparum stage V gametocytes were rendered inactive after 24 hours of 
incubation with parthenin at 1 µg/mL as evident by the complete absence of exflagellation 
and oocyst formation despite the absence of the compound in the gametocytemic blood 
meal. 
Conclusion:  Parthenin was shown to have significant effects on all tested 
developmental stages of the parasite including gametocytes, male gametes and 
ookinetes. The broad inhibitory properties of parthenin on all the evaluated parasite 
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An estimated 198 million cases of malaria and 584,000 deaths, mostly among children, 
were reported in 2013 [1]. However, as a result of concerted control efforts since 2000, 
including anti-malarial drugs, mortality has declined by 47% and the prevalence in children 
ages 2-10 has dropped by 48%; resulting in an estimated 4.3 million lives saved [1]. 
Artemisinin, delivered with a partnered drug, is one of the fastest acting antimalarial 
therapies available [2, 3]. However, antimalarial resistance in Plasmodium falciparum has 
been described recently in Southeast Asia [4]. This discovery emphasizes the need for 
novel compounds that would be effective against resistant strains, presumably by acting 
on the parasite differently from artemisinin. Artemisinin was originally isolated from 
Artemisia annua, or sweet wormwood, a member of the Asteraceae family. We 
hypothesize that natural product compounds from other related family members may 
retain potent activities against Plasmodium while targeting different biological pathways. 
 
Parthenin is a sesquiterpene lactone derived from Parthenium hysterophorus; which is an 
invasive, flowering annual weed in the Asteraceae family that grows to 2 meters in height 
with small white flowers and is spread throughout much of the world [5]. P. hysterophorus 
has been described as one of the world’s most devastating weeds because of the millions 
of dollars in damages it causes yearly from diminished agricultural productivity [6, 7]. In 
addition to its detrimental effects on agriculture, the weed also causes allergic contact 
dermatitis. The overall negative impact of the plant on agriculture and human health has 
led to numerous control efforts including herbicides, burning the plant and biological 
control with numerous arthropod species [5, 8, 9]. Conversely, there is also an interest in 




the best studied natural compounds derived from P. hysterophorus and is the main 
irritable component found throughout the plant tissue. Parthenin is secreted to inhibit 
growth of nearby plants and is the main agent responsible for allergic contact dermatitis 
[10-13]. Further studies on parthenin have revealed that it has a wide array of potentially 
beneficial biological effects and has shown activity as a potential herbicide [12, 14, 15] 
pesticide [16, 17] anti-parasitic [18, 19] and anti-cancer compound [20-23]. Parthenin may 
act through a variety of mechanisms including directly damaging DNA, inhibiting oxidative 
phosphorylation, inducing formation of nitric oxide and promoting apoptotic signaling [20, 
21, 24-27]. General cytotoxicity of parthenin has been a concern but its activity against 
different cell lines ranges greatly, the IC50 of parthenin against Jurkat cells is .061 µM and 
594 µM against HeLa cells [28]. Less toxic parthenin derivatives have also been made and 
show the potential promise of parthenin derivatives even if pure parthenin is cytotoxic 
against a number of cell lines [19, 21, 28]. 
 
Parthenin is a sesquiterpene lactone, a class of compounds that also includes the potent 
anti-malarial drug artemisinin. Artemisinin is one of a number of compounds that save 
lives by effectively treating the asexual blood stage form of Plasmodium. However, 
medicines that treat not only the asexual stages but also the transmissible forms of the 
parasite will be essential if we are to prevent the spread of new cases of malaria and bring 
about the eventual eradication of the parasite [29]. Fully mature, gametocytes (0.1-2% of 
the total parasite biomass), are the sexual, transmissible stages of Plasmodium [30]; the 
only stages that can continue the parasite life cycle in the mosquito following uptake in a 
blood meal. As the gametocytes enter the mosquito, the male and female gametes 




replication after which the male gamete sends forth its DNA in flagellated packets in a 
process called exflagellation. After the female macrogamete is fertilized, the developing 
zygote will eventually give rise to an elongated mature ookinete. After approximately 
24-36 hours the ookinete will cross the peritrophic matrix and glide along the brush border 
microvilli of the midgut epithelial cells before invading the mosquito’s midgut epithelium 
[31]. The ookinete penetrates the epithelium to the basal lamina and begins developing 
into an oocyst. After 10-20 days of development (depending on Plasmodium species) 
these oocysts will rupture, releasing thousands of sporozoites into the hemocoel, which in 
turn attach to and invade the salivary glands where they await their next opportunity to 
infect a new host during a subsequent blood meal. 
 
Understanding the biology of these parasite stages is important because very few 
antimalarial treatments that affect the asexual blood stages have an effect on the parasite 
stages involved in transmission. Artemisinin and its derivatives are one of the few 
compounds that show some efficacy against gametocytes, but its effects appear to be 
restricted to immature gametocytes, not the circulating mature stage V gametocytes 
[32-34]. Parthenin’s relatedness to artemisinin and its demonstrated activity against 
intracellular blood stages raises the possibility of an extended efficacy against the 
transmissible stages [19], most of which are extracellular, thereby increasing potential 
exposure to the compound. 
 
Provocative evidence of parthenin’s potential transmission blocking activity comes from 
studies of the sugar feeding preferences of An. gambiae in Kenya. It was observed that 
An. gambiae preferentially nectar feed on P. hysterophorus [35]. It was also shown that 




Plasmodium feed more frequently on this plant [36, 37]. Most importantly, they observed 
that when mosquitoes were provided P. hysterophorus clippings before and after feeding 
on gametocytemic blood, these mosquitoes had lower oocyst burdens compared to 
mosquitoes that were not exposed to the plant (unpublished data). Based on these initial 
studies, we hypothesized that parthenin will inhibit Plasmodium extracellular development 
in the mosquito. Importantly, although artemisinin and parthenin are derived from 
members of the same family, parthenin does not contain the endoperoxide bridge that is 
essential for artemisinin’s activity. This endoperoxide bridge is hypothesized to act as a 
prodrug requiring cleavage of bridge to induce reactive oxygen species [19, 38]. We would 
therefore predict that comparable activities against blood and mosquito stages are a result 
of different modes of action of the two compounds, which is important given the observed 
parasite resistance to artemisinin combined therapy. Furthermore, given the dynamic 
nature of the transition of gametocytes to extracellular ookinetes and oocysts, we 
hypothesize that parthenin will have a significant effect on parasite development in the 
mosquito. Here, we report on the potent transmission blocking activity of parthenin against 
P. falciparum in An. gambiae as well as its uptake by stage V gametocytes and its specific 




P. falciparum NF54 was the main parasite used for the majority of this study because P. 
falciparum is the deadliest strain of Plasmodium and clinically relevant throughout much of 
Sub-Saharan Africa. However, P. falciparum mosquito stages are difficult to culture in vitro 




CTRP-GFP strain was used to further investigate if parthenin would affect other 
Plasmodium species as well as provide a suitable strain for in vitro culture. We are 
confident that the results seen in either strain are comparable to one another and should 
not adversely affect the results of this study. 
 
Preparation of parthenin stocks 
Parthenin was isolated from whole plant tissue using methanol extraction and purified by 
HPLC [39]. The extract was dissolved into acetone and then diluted 1:10 into water to give 
a stock solution of 5 mg/mL. Parthenin purity was reconfirmed by HPLC after being 
dissolved into the acetone water mixture (Supplemental F1). 
 
Mosquito rearing and Standard Membrane Feeding Assay (SMFA) 
An. gambiae KEELE mosquitoes were maintained at the Johns Hopkins Malaria Research 
Institute Insectary. Mosquitoes were kept at 26 °C and 70% humidity with 12:12 hour 
light-dark cycles and sustained on cotton soaked in 10% sucrose. 
 
P. falciparum NF54 gametocytes were cultured in RPMI 1640 containing HEPES and 
glutamine and supplemented with 10% human serum and hypoxanthine. P. falciparum 
NF54 strain was diluted to 0.5% mixed stage asexual parasites and 4% hematocrit in 
complete culture medium in six well plates. These plates were transferred to a 37 °C 
incubator at day 15 and a microaerophilic environment was created using a desiccator 
candle jar. Media was exchanged daily from day 1 to day 17 and standard membrane 





Approximately 50 female An. gambiae mosquitoes were distributed into pint sized cups 
and starved of sugar and water for ∼12 hours prior to feeding. P. falciparum (NF54) day 
15-18 gametocyte cultures were pelleted and diluted to 0.25% or 0.1% gametocytemia 
with human blood at 50% hematocrit. Blood was washed with RPMI media and brought to 
50% hematocrit with normal AB serum. Gametocytemic blood was kept at 37 °C until 
feeding. Parthenin was diluted to appropriate concentrations in 20 µL total volume + 2 µL 
of 10x PBS. Each parthenin dilution (22 µL total volume) was added to 200 µL of 
gametocytemic blood. The gametocytemic blood was placed inside of water-jacketed 
membrane feeders at 37 °C and mosquitoes were allowed to feed for 60 minutes. After 
blood feeding, non-blood fed mosquitoes were removed from each treatment and the 
mosquitoes were kept at 26°C and 70% humidity for 8 days prior to midgut dissections. 
 
Midguts were dissected 8 days post-feeding and stained with 0.2% Mercurochrome dye in 
water for 20 minutes. Midguts were placed on a slide with a drop of PBS and oocysts were 
counted by brightfield microscopy at 200x total magnification. Where appropriate, a 
generalized linear mixed model (GLMM) or a nonparametric test (Mann-Whitney U test 
and Kruskall-Wallis one-way analysis of variance with subsequent Dunn 
multiple-comparison tests) were used to evaluate differences in oocyst intensity between 
control and treatment groups. Significance level, α=0.05. 
 
Immunofluorescence Assay 
Mosquito midguts were dissected 22 hours post infectious blood feed. The blood meal 
was separated from the midgut by nicking the bottom of the midgut and using the surface 
tension of the PBS to collect the blood meal contents. The midgut was discarded and the 




Samples were centrifuged at 3,000 RPM and washed with PBS and were centrifuged 
again and the PBS removed and the sample was blocked with 3% Bovine Serum Albumin 
for at least 30 minutes. Samples were washed 3x with PBS and probed with α-Pfs25 
antibody (1:1000) for 1 hour at room temperature. Then blood meal content was washed 
3x in PBS and then probed with an Alexa Flour 488-conjugated α-mouse secondary 
antibody (Invitrogen, Carlsbad, CA). Samples were washed 3x in PBS and then 10 µL was 
spotted onto a glass microscope slide. After drying, a drop of Prolong gold antifade 
reagent with DAPI (Invitrogen) was added before covering with a glass coverslip. Slides 
were imaged at 1000x total magnification using a Nikon 90i digital microscope and velocity 
imaging software. 
 
P. berghei ookinete production and purification 
Donor mice were infected with a frozen stock of a CTRP-GFP strain of P. berghei. After 
7-10 days another set of mice were injected with 200 µL of 0.63% phenylhydrazine in PBS 
to induce reticulocytosis. After 3 days, phenylhydrazine treated mice were infected with 
blood from a donor mouse that was at least ≥15% parasitemia. At 3 days post-infection, 
mice were given 15 mg/L sulfadiazine in their drinking water to reduce the number of 
asexual parasites. After 24 hours the number of exflagellation centers was measured for 
each mouse, and those mice with parasitized blood presenting with ≥15 exflagellation 
centers/20x field were sacrificed and blood collected by heart puncture using a 
heparinized needle. Blood was placed directly into complete ookinete culture medium and 
rocked gently for 48 hours at 19°C.  
 




L-glutamine (Sigma-Aldrich) in 1 liter, 0.2% weight per volume NaHC03, 0.05% weight per 
volume hypoxanthine (Sigma-Aldrich), 100 µM Xanthurenic acid (XA, Sigma-Aldrich), 50 
units/mL penicillin, 50 µg/mL streptomycin (100x penicillin and streptomycin, Invitrogen), 
pH 7.4. The medium is filter-sterilized and can be stored at 4 °Celsius (up to 6 months). 
Complete media is made prior to use by supplementing with heat inactivated FBS to 20% 
FBS by volume. 
 
After 48 hours, ookinetes were enriched using a MidiMACs quadromacs magnet column 
(Miltenyi Biotec) using LS columns equilibrated with 5 mL of incomplete ookinete media. 
The blood from the 48 hour ookinete culture was run through the LS column twice. The 
column was washed 3x with 5 mL of complete ookinete media. The LS column was then 
removed from the magnet and the ookinetes were eluted with 3 mL of complete ookinete 
media. Ookinetes were spun down at 3,500 RPM for 3 minutes and extra media removed 
to concentrate the samples as needed for flow cytometry. 
 
Quantification of ookinetes by flow cytometry 
P. berghei CTRP-GFP ookinetes were prepared as described, in 96 well plates, with each 
well containing 100 µL of complete ookinete media, 10 µL of parthenin in acetone at 
concentrations of 100, 50, 25, 12.5 and 6.25 µg/mL and 5 µL of gametocytemic blood from 
a single mouse.  Samples were run in sets of four and pooled during purification. 
Samples were spun down at 3,500 RPM to concentrate to 30 µL of total volume in 
complete ookinete media. After enrichment, approximately 1-8% of the cells were mature 
ookinetes.   
 




resolution imaging capabilities. Individual images of each event were recorded. The 
events were gated based on brightfield area and GFP intensity. Images were taken at 60x 
magnification and run at high speed with a 7 µm core size. To increase the speed of the 
analysis and overcome the throughput limitation of the Imagestream, only an equivalent 
portion of each sample was analyzed and the total number of ookinetes per sample was 
estimated based on the proportion analyzed. 
 
Data analysis was performed using the IDEAS version 6.0 software, with 1 x 105 to 1 x 106 
as the selected range of GFP intensities that are indicative of the fertilized parasites based 
on a visual confirmation of the live images as the parasites passed through the laser. The 
parasites were also gated based on brightfield area to exclude events that would be too 
small or large to be parasites. Each event within the gate was later individually verified as 
a parasite or another cell type. 
  
Quantification of exflagellation centers 
4 µL of P. falciparum gametocytemic blood was pipetted on a glass slide and incubated at 
room temperature for 16 minutes. After 16 minutes, exflagellation centers were counted 
across 10 random fields at 200x total magnification on a compound microscope using 
phase contrast microscopy. Counts for each sample were performed in triplicate at 
6.25-100 µg/mL parthenin. 
 
Assessment of the functional activity of stage V gametocytes 
Gametocytes were cultured as described previously except that on day 15-16, 




gametocytes were exposed to the water acetone mixture over the 24 hour time period. 
After 24 hours, the treated media was washed out and replaced with fresh media; after 
another 24 hours of exposure to the fresh media, the gametocytes were used in a SMFA. 
Midguts were dissected and oocysts counted as described as a measurement of 
gametocyte viability and infectivity to mosquitoes. 
 
Results and Discussion 
 
Exposing P. falciparum gametocytes to parthenin in the blood meal results in a 
significant decrease in oocyst intensity in the mosquito 
Addition of parthenin to gametocytemic blood at 100, 50, 25, 12.5 and 6.25 µg/mL prior to 
ingestion by the mosquitoes was shown to have a significant impact on oocyst intensity at 
100, 50 and 25 µg/mL in all three replicates (Figure 1 A and Supplementary Figure 2 A and 
B). Even at the lowest concentration of 6.25 µg/mL, median oocyst counts decreased by 
40-80%, but oocyst prevalence remained high at 88-91% (Figure 1B). The water acetone 
mixture used in the control feeds was previously observed to have negligible impact on the 
number of oocysts (data not shown). 
 
Inclusion of parthenin in the blood meal effectively shows the transmission blocking 
activity of parthenin; however, parthenin may have acted on the parasite at any of the 
developmental stages from early gametogenesis to oocyst formation. To determine the 






Parthenin decreases the numbers of zygotes and ookinetes in P. falciparum in vivo 
and P. berghei in vitro 
To explore if there is any effect of parthenin on ookinete development, mosquitoes were 
fed P. falciparum NF54 gametocytes with a high concentration of parthenin (500 µg/mL, a 
concentration at which oocysts were never observed), dissected 22 hours post blood feed 
and checked for the presence or absence of ookinetes by IFA. At this concentration, none 
of the treated mosquitoes had any ookinetes in the midgut while all the control mosquitoes 
were positive for ookinetes (Supplemental Figure 3). 
 
Due to the difficulties associated with obtaining accurate counts of total ookinetes in vivo, 
a P. berghei line expressing GFP under the control of the CTRP promoter was used in an 
ookinete in vitro culture [40].This approach allow for the precise titration of parthenin, 
under controlled culture conditions and quantification by flow cytometry.  
 
The Amnis ImagestreamX MKII system quantifies and captures the image of each GFP 
positive event (parasite), which represents only fertilized female macrogametes, zygotes, 
retorts and mature ookinetes. There was a decrease in speed at which the instrument 
could calculate total events but the ability to match an image with each event (at 600x 
magnification) was significant, as this allowed manual confirmation of the quantified 
parasites (Figure 2A). A red blood cell could be easily distinguished from a zygote or an 
ookinete (Figure 2A) and parasites obscured by other cellular debris were also verified 
(Supplemental Figure 4). 
 




in the blood meal decreases the total number of parasites prior to midgut cell invasion and 
the development of oocysts (Figure 2 B-F); corroborating our initial observations (Figure 
1). Overall 58% of the events were verified as parasites (Figure 2F). Of the three 
replicates, we determined that replicate 2 had an inordinate number of cellular debris of 
which only 46% of the positive events were intact parasites. On the other hand, the 
proportion of intact parasites in replicates 1 and 3 were 93% and 84% positive, 
respectively. Of all the parasites imaged, approximately 90% were round zygotes and 
10% were fully developed ookinetes with a small proportion of the parasites in the 
intermediate retort form (Figure 2F). It could not be ascertained definitively whether or not 
the observed ookinetes were viable, or functional, as the parasites were not sorted; 
however, we assume this to be the case given the normal ookinete morphology (Figure 
2A) and the observed development of oocysts present in vivo with matched 
concentrations of parthenin (Figure 1). 
 
Parthenin decreases exflagellation 
The observed decrease in ookinetes with increasing concentrations of parthenin suggests 
that parthenin’s impact may precede fertilization. Exflagellation may be vulnerable to the 
hypothesized effects of parthenin because parthenin has been shown to damage DNA as 
well as quickly replicating cancerous cell lines [20, 24-26]. This makes male gametes a 
potentially sensitive target because microgametogenesis and exflagellation involve 
intense DNA replication and partitioning to flagella. As suspected, we observed a 
significant decrease in the number of exflagellation centers with increasing parthenin 





This reduction of exflagellation illustrates the speed at which parthenin acts on the 
parasite, as exflagellation centers were measured after a 16 minute exposure to 
compound. The effect on exflagellation and speed at which the compound acts may give 
some insight into possible mechanisms of action, if the detected decrease in exflagellation 
centers is a result of the main mechanism of action of parthenin. Damage to the DNA or 
induction of reactive oxygen species during this time of intense DNA replication and 
cellular partitioning may be responsible for the observed effects. One mechanism of action 
that loses support in this assay as a major contributor of parthenin’s activity is that 
parthenin inhibits oxidative phosphorylation [27]. Male gametes appear to lack 
mitochondria and have been shown to rely on glycolysis quite heavily for exflagellation 
[41, 42]. Further focus on the inhibition of this specific parasite stage may be fruitful for 
trying to unravel potential mechanisms of action due to the robust activity during 
microgametogenesis. 
 
Parthenin inactivates stage V gametocytes  
Mature P. falciparum stage V gametocytes that circulate in the peripheral blood have 
proven difficult to eliminate by standard antimalarial drugs that are effective at killing 
asexual stages [34, 43]. Artemisinin is active against early gametocyte developmental 
stages, but not mature forms [32-34]. However, we wanted to know if parthenin can 
inactivate gametocytes in vitro without having to be ingested by the mosquito. We 
incubated stage V gametocytes with parthenin for 24 hours, washed the compound and 
incubated the parasites in normal culture medium prior to feeding 24 hours later. Our 
study suggests that parthenin is taken up by gametocytes and prevents exflagellation 24 
hours post-exposure which leads to a lack of oocysts 8 days later (Figure 4). Testing stage 




between the human and mosquito and while parthenin may have an effect on earlier 
gametocyte stages (I-IV), it is outside the focus of this study on parthenin’s effect on the 
mosquito developmental stages of Plasmodium. 
 
Conclusion 
Parthenin has demonstrated an ability to inhibit each of the developmental stages of 
Plasmodium against which it was tested. This broad activity seems promising for 
parthenin as a potential therapeutic, and parthenin has been used as a medicinal herb, but 
its broad range of cytotoxic effects has thus far hindered its development as a therapeutic 
[26, 39, 44, 45]. However, previous studies have shown that chemical derivatives of 
parthenin and closely related compounds have shown similar inhibitory profiles with less 
general cytotoxicity; this greater specificity has allowed these compounds to reach clinical 
trials [19, 20, 22, 46]. Notwithstanding the cytotoxicity, the demonstration of the 
compound’s antimalarial properties make it a valuable tool for investigating mechanisms 
underlying other parthenin derivatives or sesquiterpene lactones that may retain 
antimalarial activity but have a better safety profile. Studies like this become increasingly 
important as artemisinin resistance continues to grow. 
 
In conclusion, parthenin has been demonstrated as a compound with activity against 
multiple mosquito stages of the Plasmodium parasite. Further studies on parthenin’s 
mode of action could lead to the discovery of vulnerable Plasmodium pathways that are 








Figure 1. Parthenin treatment of gametocytemic blood concurrent with blood 
feeding results in lower oocyst counts.  A. Replicate (2) showing statistically 
significant decreases in P. falciparum oocyst counts at 100, 50 and 25 µg/ml. Statistical 
significance was determined using nonparametric statistical analyses (Mann-Whitney U 
test and Kruskall-Wallis one-way analysis of variance with subsequent Dunn 
multiple-comparison tests). B. Table summarizing the sample size, median oocyst 
number, % inhibition in median oocyst numbers and prevalence of infection for all three 
replicates (replicates 1 and 3 are shown in Supplementary Figure 2). 
A
B











*** = P value < 0.0001
** = P value < 0.001





















  Control 6.25 µg/ml 12.5 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml 
 
1 
Sample Size 14 18 32 20 26 24 
Median 77 15 1 0 0 0 
% Inhibition NA 80.52 98.7 100 100 100 
 
Prevalence 93.33 91.67 72.22 50 0 0 
 
2 
Sample Size 24 16 17 14 24 22 
Median 38.5 23 14 2.5 0 0 
% Inhibition NA 40.26 63.64 93.51 100 100 
 
Prevalence 92 88.24 83.33 60 28 4.35 
 
3 
Sample Size 37 45 33 39 40 30 
Median 23 10 5 0 0 0 
% Inhibition NA 56.52 78.26 100 100 100 





Figure 2. Parthenin treatment inhibits P. berghei ookinete maturation. A. Example 
images from the Amnis Imagestream mkII depicting a red blood cell (top) zygote (middle) 
and ookinete (bottom); images like these were used for the manual verification of each 
GFP positive event. B. Graph depicting total number of zygotes and ookinetes at different 
concentrations that were identified by flow cytometry and individually verified. C-E. 
Representative flow cytometry results from replicate 3 depicting an example of a control, a 
higher concentration parthenin treatment (50 µg/mL) that contained no verified parasites 
and a low concentration treatment that contained a high amount of parasites (6.25 µg/mL). 
F. Table summarizing total numbers and percentages of gated and verified parasites and 
















































































in full volume 
Total ookinetes 
in full volume 
% 
Conversion 
Replicate 1 327 304 92.97 1534 85 5.56 
Replicate 2 2266 1033 45.59 4270 472 11.05 
Replicate 3 648 544 83.95 5698 586 10.29 





Figure 3. Parthenin decreases the number of exflagellation center events in P. 
falciparum. Each bar is the mean number of exflagellation centers seen across 30 fields 
at 200x total magnification 16 to 18 minutes post induction with error bars representing the 
standard error of the mean. High gametocytemia was 1% gametocytemia, medium 
gametocytemia was .25% and low gametocytemia was .1%. In all three replicates 
exflagellation counts were markedly decreased at higher concentrations and returned to 





















































Figure 4. Co-incubation of parthenin with P. falciparum stage V gametocytes 
results in lack of exflagellation or oocysts. A. Oocyst intensity was reduced by 100 % 
at all three concentrations. B. Table showing the sample size, median oocyst number and 
% inhibition for oocyst counts from the graph in part A C. Mean exflagellation counts plus 
the standard error of the mean for the same gametocytemic blood used for the feed in part 
A; no exflagellation was observed at any of the concentrations. 









*** = P value < 0.0001
***
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 Control 100  µg/ml 10  µg/ml 1  µg/ml 
Sample Size 42 47 48 57 
Median 184 0 0 0 
% Inhibition NA 100 100 100 
Prevalence 97.67 0 0 0 









































Supplementary Figure 1. Confirmation of parthenin purity by HPLC. The red line is 
the water/acetone mixture used to dissolve the parthenin. The blue line is the same 
mixture with the addition of parthenin. The strong peak near 6 minutes illustrates the purity 











Supplementary Figure 2. Replicates further illustrating the anti-parasite activity of 
parthenin. A. Biological Replicate 1 from Figure 1 illustrating the effect of parthenin on P. 
falciparum oocyst development when added to the blood meal immediately before 
feeding. B. Biological Replicate 3 from Figure 1 illustrating the effect of parthenin on 
oocyst development when added to the blood meal immediately before feeding. C.  
Technical Replicate 2 from Figure 4 showing the effect of parthenin when incubated with 














*** = P value < 0.0001
***
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*** = P value < 0.0001





































*** = P value < 0.0001


























Supplementary Figure 3. Lack of P. falciparum ookinetes in vivo at 500 µg/mL 
parthenin.  Midgut contents were removed 22 hours post SMFA, fixed in 4% 
Paraformaldehyde, and probed with α-pfs25 antibody (1:1000) and probed again with 
Alexa Flour 488 α-mouse secondary antibody. A-C. Example ookinetes from the control 
groups that were all positive for ookinetes. D. An example image from the parthenin 
treated (500 µg/mL) mosquitoes showing that no ookinetes were present in any of the 












Supplementary Figure 4.  Sensitivity and precision of Amnis Imagestream
X 
Mark II 
instrument to decipher between GFP+ P. berghei parasites and cellular debris. 
Ch02 is GFP, Ch05 is brightfield image and Ch06 is side scatter. A. Round zygote 
obscured by a clump of cells B-C. Ookinetes that are also obscured by cellular debris but 
still detectable by GFP. These images illustrate the ability of the Imagestream to pick out 
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